Bayard F - Search Results

1

Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity.

Delarue F, Kedjouar B, Mésange F, Bayard F, Faye JC, Poirot M. Delarue F, et al. Among authors: bayard f. Biochem Pharmacol. 1999 Mar 15;57(6):657-61. doi: 10.1016/s0006-2952(98)00347-5. Biochem Pharmacol. 1999. PMID: 10037451

2

Insulin and estrogen receptor ligand influence the FGF-2 activities in MCF-7 breast cancer cells.

Garnier M, Giamarchi C, Delrieu I, Rio MC, Chinestra P, Bayard F, Poirot M, Faye JC. Garnier M, et al. Among authors: bayard f. Biochem Pharmacol. 2003 Feb 15;65(4):629-36. doi: 10.1016/s0006-2952(02)01563-0. Biochem Pharmacol. 2003. PMID: 12566092

3

Ligands of the antiestrogen binding site block endothelial cell proliferation reversibly.

Garnier M, Mésange F, Dupont MA, Gas N, Zanibellato C, Bayard F, Faye JC. Garnier M, et al. Among authors: bayard f. Exp Cell Res. 1993 Mar;205(1):191-4. doi: 10.1006/excr.1993.1075. Exp Cell Res. 1993. PMID: 8453993

4

Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.

Mesange F, Delarue F, Puel J, Bayard F, Faye JC. Mesange F, et al. Among authors: bayard f. Mol Pharmacol. 1996 Jul;50(1):75-9. Mol Pharmacol. 1996. PMID: 8700122

5

Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site.

Mésange F, Sebbar M, Kedjouar B, Capdevielle J, Guillemot JC, Ferrara P, Bayard F, Delarue F, Faye JC, Poirot M. Mésange F, et al. Among authors: bayard f. Biochem J. 1998 Aug 15;334 ( Pt 1)(Pt 1):107-12. doi: 10.1042/bj3340107. Biochem J. 1998. PMID: 9693109 Free PMC article.

6

Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cells.

Delrieu I, Faye JC, Bayard F, Maret A. Delrieu I, et al. Among authors: bayard f. Biochem J. 1999 May 15;340 ( Pt 1)(Pt 1):201-6. Biochem J. 1999. PMID: 10229675 Free PMC article.

7

A potent and selective photoaffinity probe for the anti-estrogen binding site of rat liver.

Poirot M, Chailleux C, Fargin A, Bayard F, Faye JC. Poirot M, et al. Among authors: bayard f. J Biol Chem. 1990 Oct 5;265(28):17039-43. J Biol Chem. 1990. PMID: 2211609 Free article.

8

The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.

Poirot M, Garnier M, Bayard F, Riviere I, Traore M, Wilson M, Fargin A, Faye JC. Poirot M, et al. Among authors: bayard f. Biochem Pharmacol. 1990 Aug 1;40(3):425-9. doi: 10.1016/0006-2952(90)90539-w. Biochem Pharmacol. 1990. PMID: 2383280

9

Solubilization of a tamoxifen-binding protein. Assessment of its molecular mass.

Fargin A, Faye JC, le Maire M, Bayard F, Potier M, Beauregard G. Fargin A, et al. Among authors: bayard f. Biochem J. 1988 Nov 15;256(1):229-36. doi: 10.1042/bj2560229. Biochem J. 1988. PMID: 3066343 Free PMC article.

10

Antiestrogens inhibit the replication of the retroviral Moloney murine leukemia virus in vitro.

Chailleux C, Mesange F, Bayard F, Prats AC, Faye JC. Chailleux C, et al. Among authors: bayard f. Mol Pharmacol. 1993 Aug;44(2):324-7. Mol Pharmacol. 1993. PMID: 7689144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters